Cheap drug shows promise against blood cancers in lab tests
NCT ID NCT04234022
First seen Jan 19, 2026 · Last updated May 08, 2026 · Updated 24 times
Summary
This study is testing a drug called Imuthiol (Zn-DDC) in the lab to see how well it kills blood cancer cells, including hard-to-treat cancer stem cells. Researchers will also combine it with other drugs like lenalidomide and pomalidomide. The goal is to find effective, affordable treatments for blood cancers like multiple myeloma. About 70 adults with myeloma or acute leukemia will donate samples for testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Royal Wolverhampton NHS Trust
RECRUITINGWolverhampton, WV10 0QP, United Kingdom
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.